Cargando…

Sequence‐Based In‐silico Discovery, Characterisation, and Biocatalytic Application of a Set of Imine Reductases

Imine reductases (IREDs) have recently become a primary focus of research in biocatalysis, complementing other classes of amine‐forming enzymes such as transaminases and amine dehydrogenases. Following in the footsteps of other research groups, we have established a set of IRED biocatalysts by seque...

Descripción completa

Detalles Bibliográficos
Autores principales: Velikogne, Stefan, Resch, Verena, Dertnig, Carina, Schrittwieser, Joerg H., Kroutil, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120462/
https://www.ncbi.nlm.nih.gov/pubmed/30197686
http://dx.doi.org/10.1002/cctc.201800607
_version_ 1783352274408439808
author Velikogne, Stefan
Resch, Verena
Dertnig, Carina
Schrittwieser, Joerg H.
Kroutil, Wolfgang
author_facet Velikogne, Stefan
Resch, Verena
Dertnig, Carina
Schrittwieser, Joerg H.
Kroutil, Wolfgang
author_sort Velikogne, Stefan
collection PubMed
description Imine reductases (IREDs) have recently become a primary focus of research in biocatalysis, complementing other classes of amine‐forming enzymes such as transaminases and amine dehydrogenases. Following in the footsteps of other research groups, we have established a set of IRED biocatalysts by sequence‐based in silico enzyme discovery. In this study, we present basic characterisation data for these novel IREDs and explore their activity and stereoselectivity using a panel of structurally diverse cyclic imines as substrates. Specific activities of >1 U/mg and excellent stereoselectivities (ee>99 %) were observed in many cases, and the enzymes proved surprisingly tolerant towards elevated substrate loadings. Co‐expression of the IREDs with an alcohol dehydrogenase for cofactor regeneration led to whole‐cell biocatalysts capable of efficiently reducing imines at 100 mM initial concentration with no need for the addition of extracellular nicotinamide cofactor. Preparative biotransformations on gram scale using these ‘designer cells’ afforded chiral amines in good yield and excellent optical purity.
format Online
Article
Text
id pubmed-6120462
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61204622018-09-05 Sequence‐Based In‐silico Discovery, Characterisation, and Biocatalytic Application of a Set of Imine Reductases Velikogne, Stefan Resch, Verena Dertnig, Carina Schrittwieser, Joerg H. Kroutil, Wolfgang ChemCatChem Full Papers Imine reductases (IREDs) have recently become a primary focus of research in biocatalysis, complementing other classes of amine‐forming enzymes such as transaminases and amine dehydrogenases. Following in the footsteps of other research groups, we have established a set of IRED biocatalysts by sequence‐based in silico enzyme discovery. In this study, we present basic characterisation data for these novel IREDs and explore their activity and stereoselectivity using a panel of structurally diverse cyclic imines as substrates. Specific activities of >1 U/mg and excellent stereoselectivities (ee>99 %) were observed in many cases, and the enzymes proved surprisingly tolerant towards elevated substrate loadings. Co‐expression of the IREDs with an alcohol dehydrogenase for cofactor regeneration led to whole‐cell biocatalysts capable of efficiently reducing imines at 100 mM initial concentration with no need for the addition of extracellular nicotinamide cofactor. Preparative biotransformations on gram scale using these ‘designer cells’ afforded chiral amines in good yield and excellent optical purity. John Wiley and Sons Inc. 2018-07-17 2018-08-13 /pmc/articles/PMC6120462/ /pubmed/30197686 http://dx.doi.org/10.1002/cctc.201800607 Text en © 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Full Papers
Velikogne, Stefan
Resch, Verena
Dertnig, Carina
Schrittwieser, Joerg H.
Kroutil, Wolfgang
Sequence‐Based In‐silico Discovery, Characterisation, and Biocatalytic Application of a Set of Imine Reductases
title Sequence‐Based In‐silico Discovery, Characterisation, and Biocatalytic Application of a Set of Imine Reductases
title_full Sequence‐Based In‐silico Discovery, Characterisation, and Biocatalytic Application of a Set of Imine Reductases
title_fullStr Sequence‐Based In‐silico Discovery, Characterisation, and Biocatalytic Application of a Set of Imine Reductases
title_full_unstemmed Sequence‐Based In‐silico Discovery, Characterisation, and Biocatalytic Application of a Set of Imine Reductases
title_short Sequence‐Based In‐silico Discovery, Characterisation, and Biocatalytic Application of a Set of Imine Reductases
title_sort sequence‐based in‐silico discovery, characterisation, and biocatalytic application of a set of imine reductases
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120462/
https://www.ncbi.nlm.nih.gov/pubmed/30197686
http://dx.doi.org/10.1002/cctc.201800607
work_keys_str_mv AT velikognestefan sequencebasedinsilicodiscoverycharacterisationandbiocatalyticapplicationofasetofiminereductases
AT reschverena sequencebasedinsilicodiscoverycharacterisationandbiocatalyticapplicationofasetofiminereductases
AT dertnigcarina sequencebasedinsilicodiscoverycharacterisationandbiocatalyticapplicationofasetofiminereductases
AT schrittwieserjoergh sequencebasedinsilicodiscoverycharacterisationandbiocatalyticapplicationofasetofiminereductases
AT kroutilwolfgang sequencebasedinsilicodiscoverycharacterisationandbiocatalyticapplicationofasetofiminereductases